Related Experiment Video
Updated: Jun 20, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Mechanism of simvastatin-induced K562 cell apoptosis
Yong-Chang Yang1, Dai-Wen Xiao, Hua Liu
1Clinical Laboratory Department, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Abstract:
Statins are being widely used for the therapy and prevention of several types of tumors, including human chronic myelogenous leukemia, but the underlying molecular mechanisms still remain unknown. Therefore, inhibition of cell proliferation, apoptosis and involved molecules were investigated in K562 cells after incubation with simvastatin.The results showed that simvastatin diminished K562 cell proliferation and induced apoptosis. At the same time, the level of reactive oxygen species (ROS) and intracellular calcium concentration increased. Furthermore, nitric oxide (NO) content and inducible NO synthase (iNOS) mRNA expression were significantly higher in the simvastatin-treated group than in the corresponding control group. The elevated ROS level and intracellular calcium concentration, enhanced mRNA expression of iNOS and total NO content might be responsible for the apoptotic and anti-proliferative effects of simvastatin in K562 cells.
Insights
Simvastatin, a statin, inhibits chronic myelogenous leukemia (CML) cell growth and induces apoptosis by increasing reactive oxygen species (ROS), calcium, and nitric oxide (NO) via inducible NO synthase (iNOS). These mechanisms clarify statin
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Statins are utilized in cancer therapy and prevention, but their molecular mechanisms remain unclear.
- Chronic myelogenous leukemia (CML) is a significant target for statin-based therapies.
Purpose of the Study:
- To investigate the effects of simvastatin on K562 cells, a CML cell line.
- To elucidate the molecular mechanisms underlying simvastatin's anti-cancer effects, focusing on cell proliferation, apoptosis, and related molecules.
Main Methods:
- K562 cells were treated with simvastatin.
- Assays were performed to measure cell proliferation, apoptosis, reactive oxygen species (ROS), intracellular calcium concentration, and nitric oxide (NO) levels.
- Inducible NO synthase (iNOS) mRNA expression was analyzed.
Main Results:
- Simvastatin significantly reduced K562 cell proliferation and induced apoptosis.
- Treatment with simvastatin led to increased levels of ROS and intracellular calcium.
- Elevated nitric oxide (NO) content and increased iNOS mRNA expression were observed in simvastatin-treated cells.
Conclusions:
- Simvastatin exhibits anti-proliferative and apoptotic effects on K562 cells.
- Increased ROS, intracellular calcium, and NO production via iNOS contribute to simvastatin's observed effects.
- These findings provide insights into the molecular mechanisms of statins in CML therapy.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

